According to MHRA-approved guidance, you may change your injection day provided at least three days (72 hours) have elapsed between doses
Common side effects include nausea, diarrhoea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. Some serious side effects could be inflammation of the pancreas or pancreatitis, low blood sugar level if used with another medication, serious allergic reactions, severe stomach problems, changes in vision, and gallbladder problems. If side effects show, the company says to tell your healthcare provider right away. PRECAUTIONS The company listed some warnings before using Mounjaro (tirzepatide)
This may also result in an inability to obtain approval of azelaprag or any future product candidates
Traveling with supplier invoice, MSDS, and institutional affiliation documentation (if applicable) minimizes risk of confiscation during security screening
The clinical relevance of this finding in humans is uncertain, and it is not established as a contraindication in UK Summaries of Product Characteristics for approved GLP-1 receptor agonists
Food Noise Returns One of the most commonly reported experiences after stopping is the dramatic return of "food noise" the constant mental preoccupation with eating that GLP-1 medications quiet so effectively